Are endometrial polyps true cancer precursors?

Objective The purpose of this study was to assess whether endometrial polyps (EMPs) represent cancer precursors. Study Design Age standardized incidence ratios (SIRs) of histologically verified endometrial cancers (EmCas) were estimated in women with EMPs and in women with uterine leiomyomata, which...

Full description

Saved in:
Bibliographic Details
Published in:American journal of obstetrics and gynecology 2010-09, Vol.203 (3), p.232.e1-232.e6
Main Authors: Perri, Tamar, MD, Rahimi, Kurosh, MD, Ramanakumar, Agnihotram V., PhD, Wou, Karen, MD, Pilavdzic, Dragana, MD, Franco, Eduardo L., PhD, Gotlieb, Walter H., MD, PhD, Ferenczy, Alex, MD
Format: Article
Language:eng
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective The purpose of this study was to assess whether endometrial polyps (EMPs) represent cancer precursors. Study Design Age standardized incidence ratios (SIRs) of histologically verified endometrial cancers (EmCas) were estimated in women with EMPs and in women with uterine leiomyomata, which is a condition that is unrelated to endometrial carcinogenesis. SIRs were calculated as the ratio of observed to expected EmCas based on age-specific incidence rates for female Montreal residents during the same period. Results Of 1467 women with EMPs, 125 (8.5%) had EmCa. Of 1138 patients with uterine leiomyomata, 133 (11.7%) had EmCa. The SIRs of EmCa for women with EMPs (odds ratio, 8.0; 95% confidence interval, 6.6–9.5) were significantly lower than that in women with leiomyomata (odds ratio, 19.1; 95% confidence interval, 16.0–22.6). Abnormal uterine bleeding was the main reason for evaluating patients with EMP with or without associated EmCa. Conclusion The findings of higher EmCa incidence are consistent with enhanced detection opportunity rather than with the endometrial cancer precursor potential of EMPs.
ISSN:0002-9378
1097-6868